Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-02 Sale | 2022-08-04 4:33 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $18 | $719,835 | 2,635,553 (Indirect) | View |
| 2022-07-07 Sale | 2022-07-08 4:03 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $17.17 | $686,800 | 2,675,553 (Indirect) | View |
| 2022-04-05 Sale | 2022-04-07 4:11 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 400 | $25.04 | $10,016 | 2,715,553 (Indirect) | View |
| 2021-03-24 Sale | 2021-03-24 7:12 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 17,000 | $19.02 | $323,340 | 2,715,953 (Indirect) | View |
| 2021-02-16 Sale | 2021-02-18 5:08 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 17,000 | $25.9 | $440,300 | 2,732,953 (Indirect) | View |
| 2021-02-16 Sale | 2021-02-18 5:06 pm | Inhibrx Inc. | INBX | Wagner Klaus W. Chief Medical Officer | 176,033 | $24.43 | $4,300,095 | 215,150 (Direct) | View |
| 2020-08-26 Purchase | 2020-08-28 4:29 pm | Inhibrx Inc. | INBX | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC DRAGSA 50 LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 180,219 | $18.92 | $3,409,866 | 5,305,866 (Indirect) | View |
| 2020-08-24 Purchase | 2020-08-25 7:47 pm | Inhibrx Inc. | INBX | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC DRAGSA 50 LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 131,465 | $19.39 | $2,548,688 | 5,125,647 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-05 Gift | 2022-08-08 4:22 pm | N/A N/A | Inhibrx Inc. | INBX | Kayyem Jon Faiz Director | 3,400 | $0 | 3,324,201 (Indirect) | View |
| 2022-08-02 Gift | 2022-08-02 4:52 pm | N/A N/A | Inhibrx Inc. | INBX | Kayyem Jon Faiz Director | 143,500 | $0 | 25,000 (Indirect) | View |
| 2022-05-25 Option Award | 2022-05-26 4:46 pm | N/A 2032-05-25 | Inhibrx Inc. | INBX | FORSYTH DOUGLAS Director | 15,000 | $0 | 47,259 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:38 pm | N/A 2032-05-25 | Inhibrx Inc. | INBX | Kayyem Jon Faiz Director | 15,000 | $0 | 47,259 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:34 pm | N/A 2032-05-25 | Inhibrx Inc. | INBX | Vuori Kristiina MD Director | 15,000 | $0 | 45,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:31 pm | N/A 2032-05-25 | Inhibrx Inc. | INBX | MANHARD KIMBERLY Director | 15,000 | $0 | 50,759 (Direct) | View |
| 2022-01-11 Option Award | 2022-01-25 4:50 pm | N/A 2032-01-11 | Inhibrx Inc. | INBX | Deck Kelly CFO | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-12-07 Option Award | 2021-12-07 7:43 pm | N/A 2031-12-07 | Inhibrx Inc. | INBX | Vuori Kristiina MD Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-08 5:22 pm | N/A 2031-06-07 | Inhibrx Inc. | INBX | FORSYTH DOUGLAS Director | 15,000 | $0 | 32,259 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-08 5:20 pm | N/A 2031-06-07 | Inhibrx Inc. | INBX | Kayyem Jon Faiz Director | 15,000 | $0 | 32,259 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-08 5:19 pm | N/A 2031-06-07 | Inhibrx Inc. | INBX | MANHARD KIMBERLY Director | 15,000 | $0 | 35,759 (Direct) | View |
| 2021-01-15 Gift | 2021-01-19 4:16 pm | N/A N/A | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 240,000 | $0 | 120,000 (Indirect) | View |
| 2021-01-15 Option Award | 2021-01-19 4:16 pm | N/A 2021-01-15 | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $0 | 120,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-19 4:14 pm | N/A 2031-01-15 | Inhibrx Inc. | INBX | Wagner Klaus W. Chief Medical Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-19 4:13 pm | N/A 2031-01-15 | Inhibrx Inc. | INBX | Deck Kelly CFO | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-01-15 Gift | 2021-01-19 4:10 pm | N/A N/A | Inhibrx Inc. | INBX | Lappe Mark Lappe Family Trust CEO | 500,000 | $0 | 704,462 (Indirect) | View |
| 2021-01-15 Option Award | 2021-01-19 4:10 pm | N/A 2031-01-15 | Inhibrx Inc. | INBX | Lappe Mark Lappe Family Trust CEO | 145,000 | $0 | 704,462 (Direct) | View |
| 2020-08-21 Ownership | 2020-08-25 7:46 pm | N/A N/A | Inhibrx Inc. | INBX | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC DRAGSA 50 LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 0 | $0 | 4,994,182 (Indirect) | View |
| 2020-08-21 Conversion | 2020-08-24 4:31 pm | N/A N/A | Inhibrx Inc. | INBX | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 5,829,637 | $0 | 2,129,003 (Indirect) | View |
| 2020-08-21 Conversion | 2020-08-21 4:24 pm | N/A N/A | Inhibrx Inc. | INBX | FORSYTH DOUGLAS Director | 225,688 | $0 | 598,257 (Indirect) | View |
| 2020-08-21 Option Award | 2020-08-21 4:24 pm | N/A 2030-08-20 | Inhibrx Inc. | INBX | MANHARD KIMBERLY Director | 17,259 | $0 | 17,259 (Direct) | View |
| 2020-08-18 Ownership | 2020-08-18 8:30 pm | N/A N/A | Inhibrx Inc. | INBX | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 0 | $0 | 2,129,003 (Indirect) | View |
| 2020-08-18 Ownership | 2020-08-18 7:27 pm | N/A N/A | Inhibrx Inc. | INBX | Lappe Mark Lappe Family Trust CEO 10% Owner | 0 | $0 | 3,149,714 (Indirect) | View |
| 2020-08-18 Ownership | 2020-08-18 7:27 pm | N/A 2028-11-26 | Inhibrx Inc. | INBX | Deck Kelly CFO | 0 | $0 | 115,061 (Direct) | View |
| 2020-08-18 Ownership | 2020-08-18 7:27 pm | N/A N/A | Inhibrx Inc. | INBX | Deveraux Quinn L. 10% Owner | 0 | $0 | 2,749,953 (Direct) | View |
| 2020-08-18 Ownership | 2020-08-18 7:26 pm | N/A N/A | Inhibrx Inc. | INBX | Wagner Klaus W. Chief Medical Officer | 0 | $0 | 503,367 (Direct) | View |
| 2020-08-18 Ownership | 2020-08-18 7:26 pm | N/A N/A | Inhibrx Inc. | INBX | FORSYTH DOUGLAS Director | 0 | $0 | 615,516 (Indirect) | View |
| 2020-08-18 Ownership | 2020-08-18 7:25 pm | N/A N/A | Inhibrx Inc. | INBX | Kayyem Jon Faiz Jon F. Kayyem & Paige Gates-Kayyem Family Trust Director 10% Owner | 0 | $0 | 3,413,360 (Indirect) | View |
| 2020-08-18 Ownership | 2020-08-18 7:25 pm | N/A N/A | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer 10% Owner | 0 | $0 | 2,749,953 (Indirect) | View |